Short-Term Effects of Non-Surgical Periodontal Therapy on Clinical Measures of Impaired Glucose Tolerance in People with Prediabetes and Chronic Periodontitis

References

1. ↵
   National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2011.
2. ↵
   National Institutes of Health no. 08-3892. National Diabetes Statistics, 2007. 2008.
3. ↵
   1. American Diabetes Association

   . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34(1):S62-69.

   OpenUrlFREE Full Text
4. ↵
   1. Soell M,
   2. Hassan M,
   3. Miliauskaite A,
   4. Haikel Y,
   5. Selimovic D

   . The oral cavity of elderly patients in diabetes. Diabetes Metab. 2007;33(1):S10-18.

   OpenUrlCrossRefPubMed
5. ↵
   1. Taylor GW,
   2. Nahra TA,
   3. et al

   . Is periodontal treatment associated with lower medical costs in adults with diabetes? Findings in Blue Care Network 2001-2005. 2009:1-5.
6. ↵
   1. Albandar JM

   . Underestimation of Periodontitis in NHANES Surveys. J Periodontol. 2011;82(3):337-341.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Eke PI,
   2. Dye BA,
   3. Wei L,
   4. Thornton-Evans GO,
   5. Genco RJ,
   6. CDC Periodontal Disease Surveillance workgroup

   . Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91(10):914-920.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Simpson TC,
   2. Needleman I,
   3. Wild SH,
   4. Moles DR,
   5. Mills EJ

   . Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev. 2010;(5):CD004714.
9. ↵
   1. Taubman MA,
   2. Kawai T,
   3. Han X

   . The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J Clin Periodontol. 2007;34(5):367-369.

   OpenUrlCrossRefPubMedWeb of Science
10. 1. Tatakis DN,
    2. Kumar PS

    . Etiology and pathogenesis of periodontal diseases. Dent Clin North Am. 2005;49(3):491-516.

    OpenUrlCrossRefPubMed
11. ↵
    1. Van Dyke TE

    . Inflammation and periodontal diseases: a reappraisal. J Periodontol. 2008;79(8):1501-1502.

    OpenUrlPubMed
12. ↵
    1. Lockhart PB,
    2. Bolger AF,
    3. Papapanou PN,
    4. et al

    . Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125(20):2520-2544.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Inaba H,
    2. Amano A

    . Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Implication of periodontal diseases in development of systemic diseases. J Pharmacol Sci. 2010;113(2):103-109.

    OpenUrlCrossRef
14. ↵
    1. Holt SC,
    2. Ebersole JL

    . Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000. 2005;38:72-122.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Oliver RC,
    2. Brown LJ,
    3. Loe H

    . Periodontal diseases in the United States population. J Periodontol. 1998;69(2):269-278.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Cochran DL

    . Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8):1569-1576.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Sandler S,
    2. Bendtzen K,
    3. Eizirik DL,
    4. Welsh M

    . Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro. Endocrinology. 1990;126(2):1288-1294.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Pradhan AD,
    2. Manson JE,
    3. Rifai N,
    4. Buring JE,
    5. Ridker PM

    . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-334.

    OpenUrlCrossRefPubMedWeb of Science
19. 1. Pihlstrom BL,
    2. Michalowicz BS,
    3. Johnson NW

    . Periodontal diseases. Lancet. 2005;366(9499):1809-1820.

    OpenUrlCrossRefPubMedWeb of Science
20. 1. Pickup JC,
    2. Mattock MB,
    3. Chusney GD,
    4. Burt D

    . NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40(11):1286-1292.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    1. Festa A,
    2. D'Agostino R Jr.,
    3. Howard G,
    4. Mykkanen L,
    5. Tracy RP,
    6. Haffner SM

    . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-47.

    OpenUrlAbstract/FREE Full Text
22. 1. Frohlich M,
    2. Imhof A,
    3. Berg G,
    4. et al

    . Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care. 2000;23(12):1835-1839.

    OpenUrlAbstract/FREE Full Text
23. 1. Ford ES

    . Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22(12):1971-1977.

    OpenUrlAbstract/FREE Full Text
24. 1. Grau AJ,
    2. Buggle F,
    3. Becher H,
    4. Werle E,
    5. Hacke W

    . The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996;82(3):245-255.

    OpenUrlCrossRefPubMedWeb of Science
25. 1. Kanemaki T,
    2. Kitade H,
    3. Kaibori M,
    4. et al

    . Interleukin 1beta and interleukin 6, but not tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes. Hepatology. 1998;27(5):1296-1303.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    1. Tsigos C,
    2. Papanicolaou DA,
    3. Kyrou I,
    4. Defensor R,
    5. Mitsiadis CS,
    6. Chrousos GP

    . Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab. 1997;82(12):4167-4170.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    1. American Diabetes Association

    . Executive summary: Standards of medical care in diabetes--2012. Diabetes Care. 2012;35(1):S4-S10.

    OpenUrlFREE Full Text
28. ↵
    1. Santaguida PL,
    2. Balion C,
    3. Hunt D,
    4. et al

    . Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid Rep Technol Assess (Summ). 2005;(128):1-11.
29. ↵
    1. Lu Q,
    2. Tong N,
    3. Liu Y,
    4. et al

    . Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population. Diabetes Res Clin Pract. 2009;84(3):319-324.

    OpenUrlCrossRefPubMed
30. ↵
    1. Pontes Andersen CC,
    2. Flyvbjerg A,
    3. Buschard K,
    4. Holmstrup P

    . Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J Periodontol. 2007;78(3):559-565.

    OpenUrlCrossRefPubMed
31. ↵
    1. Corsetti JP,
    2. Sparks JD,
    3. Peterson RG,
    4. Smith RL,
    5. Sparks CE

    . Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis. 2000;148(2):231-241.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    1. Noack B,
    2. Jachmann I,
    3. Roscher S,
    4. et al

    . Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol. 2000;71(6):898-903.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    1. Saito T,
    2. Shimazaki Y,
    3. Kiyohara Y,
    4. et al

    . Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res. 2005;40(4):346-353.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    1. Saito T,
    2. Murakami M,
    3. Shimazaki Y,
    4. Matsumoto S,
    5. Yamashita Y

    . The extent of alveolar bone loss is associated with impaired glucose tolerance in Japanese men. J Periodontol. 2006;77(3):392-397.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    1. Saito T,
    2. Shimazaki Y,
    3. Kiyohara Y,
    4. et al

    . The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res. 2004;83(6):485-490.

    OpenUrlAbstract/FREE Full Text
36. ↵
    1. Hayashida H,
    2. Kawasaki K,
    3. Yoshimura A,
    4. et al

    . Relationship between periodontal status and HbA1c in nondiabetics. J Public Health Dent. 2009;69(3):204-206.

    OpenUrlPubMed
37. ↵
    1. Wolff RE,
    2. Wolff LF,
    3. Michalowicz BS

    . A pilot study of glycosylated hemoglobin levels in periodontitis cases and healthy controls. J Periodontol. 2009;80(7):1057-1061.

    OpenUrlCrossRefPubMed
38. ↵
    1. Zadik Y,
    2. Bechor R,
    3. Galor S,
    4. Levin L

    . Periodontal disease might be associated even with impaired fasting glucose. Br Dent J. 2010;208(10):E20.

    OpenUrlCrossRefPubMed
39. ↵
    1. Demmer RT,
    2. Desvarieux M,
    3. Holtfreter B,
    4. et al

    . Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care. 2010;33(5):1037-1043.

    OpenUrlAbstract/FREE Full Text
40. ↵
    1. Choi YH,
    2. McKeown RE,
    3. Mayer-Davis EJ,
    4. Liese AD,
    5. Song KB,
    6. Merchant AT

    . Association Between Periodontitis and Impaired Fasting Glucose and Diabetes. Diabetes Care. 2011;34(2):381-386.

    OpenUrlAbstract/FREE Full Text
41. ↵
    Parameter on chronic periodontitis with slight to moderate loss of periodontal support. American Academy of Periodontology. J Periodontol. 2000;71(5):853-855.

    OpenUrlPubMed
42. ↵
    1. Biljak VR,
    2. Bozicevic S,
    3. Lovrencic MV,
    4. Car N

    . Performance of the statstrip glucose meter in inpatient management of diabetes mellitus. Diabetol Croat. 2010;39:105-110.

    OpenUrl
43. ↵
    1. Shephard MD,
    2. Gill JP

    . The analytical quality of point-of-care testing in the ‘QAAMS’ model for diabetes management in Australian aboriginal medical services. Clin Biochem Rev. 2006;27(4):185-190.

    OpenUrlPubMed
44. ↵
    1. Lenters-Westra E,
    2. Slingerland RJ

    . Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56(1):44-52.

    OpenUrlAbstract/FREE Full Text
45. ↵
    1. Nibali L,
    2. D'Aiuto F,
    3. Griffiths G,
    4. Patel K,
    5. Suvan J,
    6. Tonetti MS

    . Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol. 2007;34(11):931-937.

    OpenUrlCrossRefPubMedWeb of Science